Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  David, Hélène N ^a   Haelewyn, Benoît ^b,c   Degoulet, Mickael ^b,c   Colomb, Denis G ^d   Risso, Jean Jacques ^e   Abraini, Jacques H ^a,b,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE CAEN   (France)

^c CNRS   (France)

^d Navy Experimental Diving Unit   (United States)

^e INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON; N METHYL DEXTRO ASPARTIC ACID; GLUCOSE; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN SLICE; CELL DAMAGE; CONTROLLED STUDY; DRUG MECHANISM; EX VIVO STUDY; EXCITOTOXICITY; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; RAT; ANIMAL; BRAIN; BRAIN INJURY; CEREBRAL ARTERY DISEASE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; METABOLISM; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT; STATISTICAL MODEL; SYNAPSE;

ANIMALIA; RATTUS;

ANIMALS; ARGON; BRAIN; BRAIN INJURIES; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MODELS, STATISTICAL; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES;

EID: 84857496052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030934     Document Type: Article

References (46)

1. Dirnagl U, Iadecola C, Moskowitz MA, (1999) Pathobiology of ischemic stroke: An integrated view. Trends Neurosci 22: 391-397.
2. Lee JM, Zipfel GJ, Choi DW, (1999) The changing landscape of ischemic brain injury mechanisms. Nature 399: A7-14.
3. Lo EH, Moskowitz MA, Jacobs TP, (1999) Exciting, radical, suicidal: How brain cells die after stroke. Stroke 36: 189-192.
4. Petzelt C, Blom P, Schmehl W, Muller J, Kox WJ, (2003) Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci 72: 1909-1918.
5. David HN, Leveillé F, Chazalviel L, MacKenzie ET, Buisson A, et al. (2003) Reduction of ischemic brain damade by nitrous oxide and xenon. J Cereb Blood Flow Metab 23: 1168-1173.
6. David HN, Haelewyn B, Rouillon C, Lecocq M, Chazalviel L, et al. (2008) Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 22: 1275-1286.
7. David HN, Haelewyn B, Risso JJ, Colloc'h N, Abraini JH, (2010) Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 30: 718-728.
8. Homi HM, Yokoo N, Warner DS, Franks NP, Maze M, et al. (2003) The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 99: 876-881.
9. Ma D, Yang H, Lynch J, Franks NP, Maze M, et al. (2003) Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 98: 690-698.
10. Ma D, Hossain M, Chow A, Arshad M, Battson RM, et al. (2005) Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58: 182-193.
11. Abraini JH, Lemaire M, David HN, (2005) Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann N Y Acad Sci 1053: 289-300.
12. Dingley J, Tooley J, Porter H, Thoresen M, (2006) Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 37: 501-506.
13. Natale G, Cattano D, Abramo A, Forfori F, Fulceri F, et al. (2006) Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study. Ann N Y Acad Sci 1074: 650-658.
14. Yarin YM, Amarjargal N, Fuchs J, Haupt H, Mazurel B, et al. (2005) Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Hear Res 201: 1-9.
15. Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, et al. (2009) Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Critical Care 13: R206.
16. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, et al. (2007) Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signalling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 105: 562-569.
17. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, et al. (2009) Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 460: 232-236.
18. Ryang YM, Fahlenkamp AV, Rossaint R, Loetscher PD, Beyer C, et al. (2011) Neuroprotective effect of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 39: 1448-1453.
19. Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, et al. (2010) Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med 235: 886-891.
20. Haelewyn B, David HN, Colloc'h N, Colomb DG Jr, Risso JJ, et al. (2011) Interactions between nitrous oxide and tissue plasminogen activator in a rat mdel of thromboembolic stroke. Anesthesiology 115: 1044-1053.
21. Semenov N, (1989) How I can go to idea. Short moment of triumph Nauka Moscow pp. 6-19.
22. Pavlov BN, Grigoreiv AI, Smolin VV, Komordin IP, Sokolv GM, et al. (1997) Investigations of different hyperoxic, hypoxic and normoxic oxygen-argon gaseous mixtures under different barometric pressure and respiration period. In: Bennett PB, Demchenko I, Marquis RE, editors. High Pressure Biology and Medicine University of Rochester Press, NY pp. 133-142.
23. Massieu L, Del Rio P, Montiel T, (2001) Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Neuroscience 106: 669-677.
24. Wu KL, Hsu C, Chan JY, (2007) Impairment of the mitochondrial respiratory enzyme activity triggers sequential activation of apoptosis-inducing factor-dependent and caspase-dependent signalling pathways to induced apoptosis after spinal cord injury. J Neurochem 101: 1552-1566.
25. Levy DI, Sucher NJ, Lipton SA, (1990) Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons. Neurosci Lett 110: 291-296.
26. Sucher NJ, Wong LA, Lipton SA, (1990) Redox modulation of NMDA receptor-mediated Ca2+ flux in mammalian central neurons. Neuroreport 1: 29-32.
27. Haelewyn B, Chalzaviel L, Lecocq M, Risso JJ, Abraini JH, (2011) Moderately delayed post-insult treatment with normobaric hyperoxia reduces excitotoxin-induced neuronal degeneration but increases ischemia-induced brain damage. Med Gas Res 1: 2.
28. Haelewyn B, Rouillon C, Risso JJ, Abraini JH, (2008) Functional (neurologic) recovery following transient focal cerebral ischemia in the rat requires at least 80% of ipsilateral cortical and subcortical integrity. Exp Neurol 213: 238-240.
29. David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, et al. (2009) Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J Cereb Blood Flow Metab 29: 1159-1165.
30. Goto T, Suwa K, Uezono S, Ichinose F, Uchiyama M, et al. (1998) The blood-gas partition coefficient of xenon may be lower than generally accepted. Br J Anesth 80: 255-256.
31. Abraini JH, Rostain JC, Kriem B, (1998) Sigmoidal compression rate-dependence of inert gas narcotic potency in rats: implication for lipid vs. protein theories of inert gas action in the central nervous system. Brain Res 808: 300-304.
32. Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ, (2003) Gamma-aminobutyric neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 96: 746-749.
33. Schwartz-Bloom RD, Miller KA, Evenson DA, Crain BJ, Nadler JV, (2000) Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience 98: 471-484.
34. Zhang F, Li C, Wang R, Han D, Zhang QG, et al. (2007) Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. Neuroscience 150: 938-949.
35. Lazar RM, Berman MF, Festa JR, Geller AE, Matejovsky TG, et al. (2010) GABAergic but not anti-cholinergic agents re-induce clinical deficits after stroke. J Neurol Sci 292: 72-76.
36. Yamakura T, Harris RA, (2000) Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 93: 1095-1101.
37. Tapper D, Arensman R, Johnson C, Folkman J, (1974) The effect of helium-oxygen mixtures on body temperature. J Pediatric Surg 9: 597-603.
38. Sugaya T, Kitani Y, (1997) Nitrous oxide attenuates the protective effect of isoflurane on microtubule-asssociated protein2 degradation during forbrain ischemia in the rat. Brain Res Bull 44: 307-309.
39. Olney JW, Farber NB, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C, (2000) Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perpect 108 (suppl 3): 383-388.
40. Abraini JH, David HN, MacKenzie ET, Lemaire M, (2005) Postischemic nitrous oxide alone versus intraischemic nitrous oxide in the presence of isoflurane: What it may change for neuroprotection against cerebral stroke in the rat. Anesth Analg 101: 614.
41. Sanders RD, Ma D, Maze M, (2005) Anesthesia-induced neuroprotection. Best Pract Res Clin Anesthesiol 19: 461-474.
42. Nasu I, Yokoo N, Takaoka S, Takata K, Hoshikawa T, et al. (2006) The dose-dependent effects of isoflurane on outcome from severe forebrain ischemia in the rat. Anesth Analg 103: 413-418.
43. Istaphanous GK, Howard J, Nan X, Hughes EA, McCaan JC, et al. (2011) Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice. Anesthesiology 114: 578-587.
44. Singhal AB, Dijhuizen RM, Rosen BR, Lo EH, (2002) Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 58: 945-952.
45. Mickel HS, Vaishnav YN, Kempski O, (1987) Breathing 100% oxygen after global brain ischemia in Mongolian gerbils results in increased lipid peroxydation and increased mortality. Stroke 18: 426-430.
46. White PF, Johnston RR, Eger EI 2nd, (1974) Determination of anesthetic requirement in rats. Anesthesiology 40: 52-57.